These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 8506338)

  • 21. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.
    Dzierszinski F; Pepper M; Stumhofer JS; LaRosa DF; Wilson EH; Turka LA; Halonen SK; Hunter CA; Roos DS
    Infect Immun; 2007 Nov; 75(11):5200-9. PubMed ID: 17846116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway.
    Suzue K; Zhou X; Eisen HN; Young RA
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13146-51. PubMed ID: 9371814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection.
    Mandal M; Lee KD
    Biochim Biophys Acta; 2002 Jun; 1563(1-2):7-17. PubMed ID: 12007619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of cytotoxic T lymphocytes following immunization with cationized soluble antigen.
    Ikenaga T; Yamasaki Y; Shakushiro K; Nishikawa M; Takakura Y
    Vaccine; 2004 Jun; 22(20):2609-16. PubMed ID: 15193386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.
    Shen Z; Reznikoff G; Dranoff G; Rock KL
    J Immunol; 1997 Mar; 158(6):2723-30. PubMed ID: 9058806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo.
    Kim TS; Chung SW; Kim SH; Kang BY; Hwang SY; Lee JW
    Cancer Gene Ther; 2000 Jun; 7(6):861-9. PubMed ID: 10880016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy.
    Chamoto K; Wakita D; Narita Y; Zhang Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
    Cancer Res; 2006 Feb; 66(3):1809-17. PubMed ID: 16452242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway.
    Nakanishi T; Hayashi A; Kunisawa J; Tsutsumi Y; Tanaka K; Yashiro-Ohtani Y; Nakanishi M; Fujiwara H; Hamaoka T; Mayumi T
    Eur J Immunol; 2000 Jun; 30(6):1740-7. PubMed ID: 10898512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I-mediated antitumor immunity.
    Kim KW; Kim SH; Jang JH; Lee EY; Park SW; Um JH; Lee YJ; Lee CH; Yoon S; Seo SY; Jeong MH; Lee ST; Chung BS; Kang CD
    Cancer Immunol Immunother; 2004 Apr; 53(4):315-22. PubMed ID: 14685778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.
    den Haan JM; Lehar SM; Bevan MJ
    J Exp Med; 2000 Dec; 192(12):1685-96. PubMed ID: 11120766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of both MHC class I- and class II-restricted antigenic peptides from exogenously added ovalbumin in murine phagosomes.
    Muno D; Kominami E; Mizuochi T
    FEBS Lett; 2000 Jul; 478(1-2):178-82. PubMed ID: 10922492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.
    Hjálmsdóttir Á; Bühler C; Vonwil V; Roveri M; Håkerud M; Wäckerle-Men Y; Gander B; Johansen P
    Mol Pharm; 2016 Feb; 13(2):320-9. PubMed ID: 26704885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.
    Wu CC; Liu SJ; Chen HW; Shen KY; Leng CH
    Oncotarget; 2016 May; 7(21):30804-19. PubMed ID: 27127171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.
    Pouniotis DS; Esparon S; Apostolopoulos V; Pietersz GA
    Immunol Cell Biol; 2011 Nov; 89(8):904-13. PubMed ID: 21383765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses.
    Ke Y; Li Y; Kapp JA
    Eur J Immunol; 1995 Feb; 25(2):549-53. PubMed ID: 7875219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells.
    Liu T; Chambers B; Diehl AD; Van Kaer L; Jondal M; Ljunggren HG
    J Immunol; 1997 Dec; 159(11):5364-71. PubMed ID: 9548476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens.
    Wijburg OL; van den Dobbelsteen GP; Vadolas J; Sanders A; Strugnell RA; van Rooijen N
    Eur J Immunol; 1998 Feb; 28(2):479-87. PubMed ID: 9521056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells.
    Pulaski BA; Yeh KY; Shastri N; Maltby KM; Penney DP; Lord EM; Frelinger JG
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3669-74. PubMed ID: 8622994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-3-mediated enhancement of particulate antigen presentation by macrophages.
    Lord EM; Yeh KY; Moran JA; Storozynsky E; Frelinger JG
    J Immunother; 1998 May; 21(3):205-10. PubMed ID: 9610912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.